Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gout in solid organ transplantation: a challenging clinical problem.

Lisa Stamp1, Martin Searle, John O'Donnell

  • 1Department of Medicine, Christchurch School of Medicine and Health Sciences, University of Otago, Christchurch, New Zealand. lisa.stamp@cdhb.govt.nz

Drugs
|January 6, 2006
PubMed
Summary

Gout and hyperuricaemia are common in organ transplant recipients, impacting quality of life. Effective management requires addressing risk factors, treating acute attacks, and initiating careful urate-lowering therapy with monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective epidemiological study in an Aotearoa New Zealand cohort.

The New Zealand medical journal·2026
Same author

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD).

Annals of the rheumatic diseases·2026
Same author

Minimally invasive first rib resection for symptomatic thoracic outlet syndrome: a case report.

Journal of spine surgery (Hong Kong)·2026
Same author

A novel case of autosomal recessive CARD11 loss-of-function underlying impaired antiviral immunity and a review of literature.

Clinical & translational immunology·2026
Same author

Elucidating the binding and metabolic interactions of sunitinib and sorafenib with Cytochrome P450s CYP2U1 and CYP2D6.

Molecular pharmacology·2026
Same author

Numerical Investigation of Impulse Noise Propagation Into the Human Head.

Journal of biomechanical engineering·2025

Area of Science:

  • Nephrology
  • Rheumatology
  • Transplantation

Background:

  • Hyperuricaemia and gout affect a significant percentage of solid organ transplant recipients.
  • Gout can severely impair the quality of life for transplant patients.
  • Ciclosporin therapy is an identified risk factor for gout in this population.

Purpose of the Study:

  • To review the challenges and strategies for managing gout in solid organ transplant recipients.
  • To highlight the complexities of pharmacological treatments due to drug interactions and patient comorbidities.

Main Methods:

  • Review of existing literature on gout and hyperuricaemia in transplant recipients.
  • Analysis of risk factors, treatment options for acute attacks, and long-term urate-lowering therapies.

Related Experiment Videos

  • Consideration of drug interactions, renal function, and cardiovascular risk factors.

    • Main Results:

    • Gout management is complicated by potential adverse effects and drug interactions, particularly with immunosuppressants.
    • NSAIDs, colchicine, and corticosteroids are options for acute attacks, requiring caution due to renal and other risks.
    • Long-term urate-lowering therapy is crucial, with allopurinol and benzbromarone having specific indications and precautions.
    • Certain antihypertensives (amlodipine, losartan) and statins (atorvastatin) may offer benefits in managing hyperuricaemia.

    Conclusions:

    • Gout in solid organ transplant recipients is a growing clinical challenge impacting patient well-being.
    • Successful management hinges on recognizing and mitigating risk factors, prompt acute treatment, and judicious initiation of hypouricaemic therapy with close monitoring.